BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6180571)

  • 1. [Treatment of non-seminomatous testicular tumors in combination with vinblastine/bleomycin and adriamycin/cisplatin].
    Boewer C; Fleck H; Uibel M; Nawka S
    Z Urol Nephrol; 1982 May; 75(5):315-23. PubMed ID: 6180571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential combination chemotherapy with vinblastine-bleomycin and doxorubicin-cis-dichlorodiammineplatinum(II) in disseminated nonseminomatous testicular cancer.
    Scheulen ME; Seeber S; Schilcher RB; Meier CR; Schmidt CG
    Cancer Treat Rep; 1980; 64(4-5):599-609. PubMed ID: 6159077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential combination chemotherapy and surgery for disseminated testicular cancer: cis-dichlorodiammineplatinum(II), vinblastine, and bleomycin remission-induction therapy followed by cyclophosphamide and adriamycin.
    Garnick MB; Canellos GP; Richie JP; Stark JJ
    Cancer Treat Rep; 1979; 63(9-10):1681-6. PubMed ID: 91438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinblastine, bleomycin, and cis-dichlorodiammineplatinum(II) in disseminated testicular cancer: preliminary report of a Southwest Oncology Group Study.
    Samson MK; Stephens RL; Rivkin S; Opipari M; Maloney T; Groppe CW; Fisher R
    Cancer Treat Rep; 1979; 63(9-10):1663-7. PubMed ID: 91435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modern chemotherapy of a malignant testicular tumors (author's transl)].
    Arnold H; Fiebig HH
    Radiologe; 1981 Sep; 21(9):421-30. PubMed ID: 6170087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy with cis-dichlorodiammineplatinum(II) in disseminated testicular cancer.
    Einhorn LH
    Cancer Treat Rep; 1979; 63(9-10):1659-62. PubMed ID: 91434
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of metastatic nonseminomatous testicular cancer: a preliminary report of induction chemotherapy followed by maintenance chemotherapy or radiotherapy.
    Sonntag RW; Senn HJ; Cavalli F
    Cancer Treat Rep; 1979; 63(9-10):1669-74. PubMed ID: 91436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sequential combination chemotherapy with vinblastine/bleomycin and adriamycin/cis-dichlorodiammineplatinum (II) in non-seminomatous testicular cancer. II. Long-term results of a study with 140 patients with retroperitoneal disease (stage II) (author's transl)].
    Scheulen ME; Bierbaum W; Niederle N; Eickenberg HU; Holfeld H; Seeber S; Schmidt CG
    Klin Wochenschr; 1980 Aug; 58(16):823-8. PubMed ID: 6161274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of disseminated seminoma.
    Einhorn LH; Williams SD
    Cancer Clin Trials; 1980; 3(4):307-13. PubMed ID: 6159120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in the therapy of testicular teratoid tumors].
    Seeber S
    Wien Med Wochenschr; 1982 Jul; 132(13-14):329-33. PubMed ID: 6182701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sequentially alternating chemotherapy of non-seminomatous testicular tumors with adriamycin/cisplatin and bleomycin/vinblastine. Therapeutic success and failure with respect to histology and tumor stages].
    Schütte J; Bremer K; Niederle N; Schoetensack B; Schmidt CG; Seeber S
    Onkologie; 1983 Feb; 6(1):16-20. PubMed ID: 6189038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.
    Culine S; Theodore C; Farhat F; Bekradda M; Terrier-Lacombe MJ; Droz JP
    J Surg Oncol; 1996 Mar; 61(3):195-8. PubMed ID: 8637206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of combination chemotherapy with cis-diamminedichloroplatinum for advanced genitourinary carcinoma].
    Nakatsu H; Nishimoto K; Moriyama H; Ehara S; Igawa M; Ishino T; Kodama M; Fujii M; Ukai R; Nihira H
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):702-9. PubMed ID: 6892199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for disseminated testicular cancer.
    Einhorn LH; Donohue JP
    Urol Clin North Am; 1977 Oct; 4(3):407-26. PubMed ID: 76358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sequential combination chemotherapy with vinblastine/bleomycin and adriamycin/cis-dichlorodiammineplatinum (II) in non-seminomatous testicular cancer. I. Results of a prospective randomized phase III-study with 71 patients with disseminated disease (stage IV) (author's transl)].
    Scheulen ME; Higi M; Schilcher RB; Meier CR; Seeber S; Schmidt CG
    Klin Wochenschr; 1980 Aug; 58(16):811-21. PubMed ID: 6161273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
    Schmidt P; Haas RJ; Göbel U; Calaminus G
    Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases].
    Ikeda I; Shuin T; Yao M; Kubota Y; Hosaka M
    Hinyokika Kiyo; 1993 Mar; 39(3):237-42. PubMed ID: 7685142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinblastine, intermittent bleomycin, and single-dose cis-dichlorodiammineplatinum(II) in the management of stge III testicular cancer.
    Bosl GJ; Kwong R; Lange PH; Fraley EE; Kennedy BJ
    Cancer Treat Rep; 1980; 64(2-3):331-4. PubMed ID: 6157467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variables for predicting serious toxicity (vinblastine dose, performance status, and prior therapeutic experience): chemotherapy for metastatic testicular cancer with cis-dichlorodiammineplatinum(II), vinblastine, and bleomycin.
    Krikorian JG; Daniels JR; Brown BW; Hu MS
    Cancer Treat Rep; 1978 Oct; 62(10):1455-63. PubMed ID: 81719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for testicular cancer: current status of the National Cancer Institute Combined Modality Trial.
    Anderson T; Javadpour N; Schilsky R; Barlock A; Young RC
    Cancer Treat Rep; 1979; 63(9-10):1687-92. PubMed ID: 91439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.